In this regard, the inhibition of the HGF/cMET pathway may, therefore, represent a valid therapeutic approach for rectal cancer patients treated with preoperative chemoradiation, as it could potentially improve outcome by decreasing radiation-induced HGF up-regulation and metastatic potential [71]. Here, HGF is linked to rectal cancer.